ILSI-Biomed Israel

Israel: America’s Technology Farm System

In the accompanying video that’s just under 30 minutes long, Steve Forbes personally interviews George Gilder for an episode of Intelligent Investing. At about the 6:30 mark, Forbes asks Gilder about the companies he feels are at the forefront of leading edge technologies today and Gilder begins talking about Israel, whose companies are “…genius under the gun…a very productive environment.” In the ensuing exchange, Forbes probes Gilder on his claim that Israel is “a functional part of th...

Israel Seeks U.S. Biotech Investors as Index Plunges

The Tel Aviv Stock Exchange is seeking to lure investment to biomedical companies after the life sciences index fell twice as much as a measure for technology stocks. “Part of the volatility was because investors weren’t familiar with these companies,” said Tel Aviv Stock Exchange Chief Executive Officer Ester Levanon. “We’re trying to bring the biomed companies closer to investors and raise the awareness of their businesses.” The Tel Aviv Biomed Index of 27 companies dropped 21 perc...

A French Delegation in the Negev

A French delegation has visited today (Sunday, 13.6.2010) at Ben-Gurion University, as the guest of Bio-Negev, the international center for innovation in the biotechnology industry and life sciences in the Negev. The purpose of the visit is to examine potential collaboration between the visitors and the new initiative in the Negev, BGU being one of the partners in the project. Prof. Rivka Carmi, president of the university, places a great amount of value in the initiative, which can be direct...

Israel’s Life Sciences Export On the Rise

The Coming ILSI–Biomed Israel 2010 Week: The Israel Export and International Cooperation Institute: Life Sciences Export Rose by 14% on the First Quarter of 2010, Summing up to the Total of ca. $1.7 Billion “The first 2010 quarter export of the life sciences industry summed up to ca. $1.7 billion, an increase of about 14 percent compared to the same period last year. This increase is derived from a 15.4 percent increase in the export of medications, which has summed up to ca. $1.3 Billion...

Biotech co D Medical files for Nasdaq listing

Biotech co D Medical files for Nasdaq listing: If the offering is successful, it will greatly dilute the holdings of its current shareholders.  The management of medical device holding company D Medical Industries Ltd. (TASE:DMDC) are not deterred by the falls on the Tel Aviv Stock Exchange (TASE) and on Wall Street over the past few weeks. The company today announced that it has filed a draft prospectus with the US Securities and Exchange Commission (SEC) for a public offering and reques...

Startup Weekly: ProtAb – Antibodies Against Arthritis

ProtAb is a company dedicated to eveloping an antibody for the treatment of Rheumatoid Arthritis and other autoimmune diseases such as Crohn's Disease, and has recently raised $4 million. Name: ProtAb CEO: Shira Yair Sector: Biopharma Medical Field: Autoimmune Diseases Est.: 2005 Stage: Late stage pre-clinical, after series A funding Vision: To develop a novel therapeutics for autoimmune diseases, based on the induction of natural anti-inflammatory mechanisms existing in...

Enzymotec: a $20 M Deal with Daiichi Sankyo

Israeli biotech company Enzymotec Ltd., a developer of active pharmaceutical ingredients for nutritional supplements, has signed a major strategic agreement with Daiichi Sankyo Brazil, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. (TSE: 4568). Globes, 6 May Enzymotec and Daiichi Sankyo Brazil will launch Enzymotec's product for the reduction of cholesterol and triglycerides, which Daiichi Sankyo Brazil will market. Daiichi Sankyo Brazil focuses on cardiology a...

June 13th: From Idea to Bench to Bedside – a Biomedical Innovation Summit

Medical Innovation:  From Idea to Bench to Bedside A Biomedical Innovation Summit Dan Panorama Tel Aviv ¡ Sunday, June 13, 2010     Presented by Cleveland Clinic Global Cardiovascular Innovation Center Israel Life Sciences Industries   And Sponsored By GT Greenberg Traurih, MPR, PriceWaterhouseCoopers, Team Neo, Cleveland Plus Business         Program 8:45                 Registration, Breakfast, Networking 9:15                 Welcome and Introductions                ...

May 5th: Healthcare Reform Webinar

U.S. Health Care Reform Webinar - A Special Presentation for Israeli Pharma, Biotech and Medical Device Companies and Their Investors     Please register for this live webinar.   Meeting Description:    Drug and Biologics Manufacturers: Medicare and Medicaid drug coverage changes Annual fee for branded prescription drug manufacturers Biosimilars   Medical Device Manufacturers: Excise tax Essential Health Benefits Package   Heal...

June 15th, 2010: A Meeting with the Sheba & Rambam Campus Scientists